mens health Flashcards

(63 cards)

1
Q

Major Male Health Issues

Associated with Advancing Age

A
Coronary Heart Disease
LUTS - lower urinary tract symptoms
BPH
Prostate Cancer
Testicular Cancer
Erectile Dysfunction
Hypogonadism “Andropause”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

prostate cancer is most common in what race

A

blakc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PSA screening

A
screening for prostate cancer
currently very controversial
leading to too many false positives*** - subsequent tests and biopsies
begin screening at age 40
f/u every 2-4 years based on risk
f/u every year in high risk groups
value of screening in over 75 yo ???
More specific testing???
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

serum testosterone pattern

A

kick starts puberty then decreases with age
200 - 900 - 200
peaks at around 22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

role of testosterone

A
Bone and muscle growth
Hair growth
Sexual organ maturation
Spermatogenesis
Increased libido
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hypogonadism

A
Hormonal deficiency (“Andropause”)
Risk Factors: Aging, Chronic Illness (Diabetes, AIDS, Rheumatoid arthritis, CKD), Long-term use of corticosteroids, Obesity 
testosterone deficiency symptoms: decreased libido, weight gain, loss of energy, may play some role in ED
diagnosis: low testosterone WITH specific signs and symptoms, must have both for diagnosis, initial test done in the AM to measure total testosterone and confirm with second test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

total testosterone level under ___ is positive for low testosterone

A

300 ng/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

confirmation of low testosterone

A

A total testosterone test or free testosterone test should be repeated to confirm diagnosis.
Because testosterone is bound to Sex Hormone Binding Globulin (SHBG), a free testosterone test should be performed in patients that are suspected of having altered SHBG concentrations.
Free testosterone level under 5 ng/dl confirms low
testosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

conditions that could decrease SHBG

A

Moderate obesity
Nephrotic syndrome
Hypothyroidism
Use of glucocorticoids, progestins, and androgenic steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

conditions that could increase SHBG

A
Aging
Hepatic cirrhosis
Hyperthyroidism
Use of anticonvulsants
Use of estrogens
HIV infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

many formulations of testosterone replacement products

A
Patches
Gels
Solutions
IM depo
Buccal
SQ Pellets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

testosterone injection

A

Testosterone enanthate or cypionate, 75-100 mg IM weekly or 200 mg every two weeks
Supraphysiologic conc during part of dosing interval – possible mood swings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

testosterone patch

A

One to two 5 mg patches applied nightly* over the skin of the back, thigh, or upper arm, away from pressure areas.
**Most similar to physiologic testosterone levels.
Avoid prolong exposure to H2O for 3 hrs after application.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

testosterone gel

A

5–10 g of a 1% testosterone gel applied daily over a covered area of non-genital skin.

  • Shoulders, upper arms, abdomen
  • Patients should wash hands after application
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

testosterone solution

A

30mg – 120mg (1 to 4 applications) applied to the arm pits once daily.

  • Wash hands after use.
  • Apply deodorant prior to application.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

testosterone buccal tablet

A

30 mg of a bioadhesive buccal testosterone tablet applied to buccal mucosa every 12 hours.
-Do not chew or swallow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

testosterone SQ pellets

A

Pellets implanted SQ at intervals of 3 to 6 months

  • Dose and regimen vary with the formulation used.
  • Onset delayed 3-4 months with first dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

testosterone contraindications

A

Prostate cancer
Breast cancer
Hematocrit > 50%
Baseline PSA greater than 4 ng/ml, or PSA >
3 ng/ml in men at high risk of prostate cancer
Recent or poorly controlled CVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

testosterone black box warning

A

Black Box Warning for Gel formulation: Concerns with secondary exposure to children.
There is some controversy regarding the cardiac risk associated with testosterone supplementation - Injection more than patches and gels
On 9/18/14, the FDA Advisory Panel voted to impose strict new limitations on the multibillion-dollar testosterone drug industry.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

testosterone monitoring

A

Patients should be monitored 3 to 6 months after initiating therapy.

  • Testosterone levels should be measured with a goal between 400 and 700 ng/dL
  • Hematocrit should be measured: if over 54%, therapy should be stopped and reinitiated when it drops to a safe level.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

androgen misuse and abuse

A
Androgen therapy has been misused by athletes to increase physical capabilities.
Potential side effects of supraphysiologic doses:
-Gynecomastia
-Weight gain
-Acne
-Decreased testicular size
-Mood alteration
-Hepatotoxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

BPH pathophysiology

A

normal size gland (under 20 g)
surrounds the proximal urethra
growth is common after age 40
contains several types of tissue: Embedded with alpha-1a adrenergic receptors, Stimulation by NE results in smooth muscle contraction with subsequent narrowing of urethra
Type-II 5-alpha reductase in the prostate gland: Converts testosterone to dihydro-testosterone [DHT], High concentrations also found in scalp
Dihydro-testosterone [DHT]: responsible for prostate enlargement and growth, some men appear to be genetically predisposed to producing large quantities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

BOO

A
bladder outlet obstruction
Decreased force of stream
Hesitancy to initiate voiding
Strain or push to urinate
Terminal dribbling
Intermittency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

irritative symptoms

A
Secondary to incomplete bladder emptying
Nocturia
Frequency
Urgency
Dysuria
Urge incontinence
QOL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
diagnosis of BPH made by
clinical symptoms digital exam measuring flow rate measuring residual volume: Bladder scan, over 25-30ml AUA Symptom Score (mild 1-7; moderate 8-19; severe 20-35) - treatment depends on severity
26
complications of BPH
chronic renal failure overflow urinary incontinence recurrent UTIs diminished quality of life
27
role of pharmacist in BPH
Advise on OTC products Encourage evaluation - especially if at high risk for prostate CA Advise on proper use of Rx medications Screen for potential ADRs from meds
28
goals of BPH therapy
Control symptoms Decrease AUA score by at least 3 pts Prevent Complications Delay need for surgery
29
treatment of BPH
Watchful waiting. | Only treat when symptoms adversely impact QOL
30
non-drug BPH therapy for all patients
Avoid drugs with strong anti-cholinergic properties: decreases contractility of bladder detrusor muscle, results in urinary retention Examples: Antihistamines (esp 1st gen, Ex: Benadryl®), Tricylcic antidepressants, Cogentin®, Artane®, Scopolamine, Anti-muscarinics (Ditropan®) Approximately half of men with BPH also have OAB. Men with both have better symptom control using a combo of alpha-antagonists plus anti-muscarinics. **Anti-muscarinics should be avoided in BPH pts with post-void residual over 200 ml and/or max urine flow rate of under 5 ml/sec. Restrict fluid, EtOH, and caffeine intake in PM Avoid diuretics and nasal decongestants, if possible. Use Kegel exercises
31
mild BPH drug therapy
Non-drug measures Some pts stabilize and do not progress Self-treatment with CAM therapy
32
moderate BPH drug therapy
Non-drug measures Alpha-blockers +/- Hormone therapy PDE Inhibitors
33
Alpha-1a Adrenergic Blockade
``` Developed for tx of HTN Relaxes smooth muscle tone of prostate gland and bladder neck - improves urine flow Does NOT reduce size of prostate gland Onset in 1-6 weeks Decreases AUA score by 30-40% Equal clinical effectiveness between all agents notice improvement in around 1 week treat HTN separately ```
34
Alpha-1 adrenergic blockers dosing
Alfuzosin* - 10 mg QD - do not crush Doxazosin - start 1 mg QHS, up to 4-8 mg QHS Silodosin* - 4 mg QD; 4-8 mg QD taken with a meal** Tamsulosin* - 0.4 mg QD, 0.4-0.8 mg QD taken half hour before same meal each day - do not crush Terazosin - 1 mg QHS; 10-20 mg QHS
35
alpha-1 adrenergic blockers side effects
**dizziness fatigue HA orthostatic hypotension retrograde ejaculation **Intra-operative Floppy Iris Syndrome has been observed during cataract surgery in some patients treated with alpha-1 blockers, especially tamsulosin. Complicate the procedure and increase the risk of post-op complications. Inquire about cataracts when first filling Rx for tamsulosin.
36
PDE inhibitors
May be indicated if pt also has ED Effectiveness similar to alpha antagonists - Tadalafil 5 mg daily Relaxes smooth muscle tone of prostate gland and bladder neck - improves urine flow
37
hormonal therapy
5-alpha reductase inhibitors which decreases dihydrotestosterone (DHT) production decreases size of prostate gland by 20 - 25% men with prostate over 40 grams benefit most onset of action may be as long as six months MAY decrease risk of prostate cancer Side effects are usually mild and transient (15% d/c tx during the first year) Impotence, decreased libido, decreased ejaculatory volume, breast tenderness **Decreases PSA by 50% in 6 months Category X - Women (in child bearing years) should avoid handling tablets
38
finasteride
moderate BPH hormone therapy 5 mg PO QD t1/2: 3-16 hours
39
dutasteride
moderate BPH hormone therapy 0.5 mg PO QD t1/2: 6 weeks
40
combination therapy for BPH
``` more effective than either agent alone finasteride+tamsulosin duasteride+tamsulosin finasteride+tadalafil : BPH + ED tamsuloson+tolterodine : BPH + OAB ```
41
treatment of severe BPH
Minimally Invasive Therapies: Transurethral microwave thermotherapy [TUMT], Transurethral needle ablation [TUNA], Prostatic stent placement, Interstitial laser coagulation, Balloon Dilation [TUDP], High-intensity focused ultrasound therapy Benefits may be short-lived Risk of acute urinary retention immediately following procedure Invasive Surgical Therapies: Transurethral Incision of the Prostate [TUIP], Transurethral Resection of the Prostate [TURP], Transurethral electrovaporization, Transurethral laser enucleation, Open prostatectomy
42
ED definition
a consistent inability to obtain or sustain an erection sufficient for intercourse in at least 50% of attempts
43
etiology of ED
15-25% of 65 YO 50% of 75 YO diseases and conditions - DM, HTN, CAD, MS, parkinsons physical: injury, surgery, medicine, radiation unhealthy lifestyle: excessive EtOH, tobacco, obesity, inadequate sleep, stress fatigue/lack of time??? "if you dont use it, youll lose it" ***
44
drug induced sexual dysfunction
antideppresants, antihypertensives, estrogen/anti-androgen, chemo
45
step wise treatment ED
1: treat or eliminate known causes 2: oral PDE-5 inhibitors 3: intraurethral or intracavernous tx 4: possible combination therapy 5: penile prosthesis
46
treatment of drug induced ED
d/c drug if possible, select agent with lower risk of ED | use oral PDE5 inhibitor
47
treatment or organic ED
Evidence of hormonal deficiency - Treat hypogonadism, Low testosterone levels with symptoms (decreased libido), under 300 ng/dL * *Rarely the cause of ED * *oral phosphodiesterase inhibitor if no contraindications * *vacuum erection device - if not a candidate for PO tx * *intra-urethral or intra-cavernosal therapy - if nothing else effective
48
treatment of psychogenic ED
counseling with partner | oral agents
49
oral therapies for ED
**first-line treatment of choice for most patients originally studied as tx for angina promotes smooth muscle relaxation in the penis by inhibition of phosphodiesterase-5 - Inhibits the hydrolyzation of cGMP to 5’ GMP sexual stimulation is required
50
PDE5 inhibitor examples
sildenafil start at 50 mg, max at 100, onset in 30 min, duration 4 hours, dose adjust for renal disease, DI with CYP3A4 inhibitors, lower dose w alpha blocker, take on empty stomach vardenafil start at 10 mg, max 20 mg, onset 30 min, duration 4 hours, take on empty stomach tadalafil 2.5-5mg daily, start at 10mg, max 20 mg, onset 60 min, duration 36 hours, dose adjust for renal disease, wont decrease BP, indicated for BPH, daily low dose may be more effective for some patients avanafil start 100 mg, max 200 mg, onset 30 min, duration 6 hours, DI with CYP3A4 inhibitors, lower dose w alpha blocker
51
PDE5 inhibitors pearls
30-40% of patients do not respond -if not…try a larger dose -**Adjust dose to produce an erection that lasts no longer than 1 hour No known tachyphylaxis over time
52
PDE5 inhibitors drug interactions
CYP3A4 Inhibitors -cimetidine, ketoconazole, erythromycin, ritonavir, grapefruit juice, others -prolongs the effect of the drugs food delays* absorption -Fatty meal can delay absorption of sildenafil and vardenafil by 1 additional hour
53
PDE5 inhibitor SEs
*Most are mild and self-limiting headache (10%), flushing (10%), dyspepsia (7%), nasal congestion, lower back and limb pain (Tadalafil only), light sensitivity; blue tinge to vision (2-3%), NAION (nonarteritic ischemic optic neuropathy)??? - sudden vision loss
54
PDE5 inhibitors precautions
***patients on oral or transdermal nitrates: DO NOT USE Dosing of nitrate after: -Viagra/Levitra: 24 hrs -Cialis: 48 hrs -patients on oral or transdermal nitrates -patients on alpha-blockers (start at lower dose) -patients with very severe CAD
55
PDE5 inhibitors patient educations
Taking on demand vs. daily dosing - 1-2 hours prior to intercourse Dosing with respect to meals Report erections that last over 4 hours !!! Report any visual or hearing complaints Report palpitations or dizziness Avoid with nitrates
56
PDE5 inhibitos for pulmonary hypertension
Sildenafil: Revatio 20 mg PO TID - generic available Tadalafil: Adcirca 40 mg PO once daily
57
vacuum erection devices
``` **very effective (satisfaction rate up to 60-80%) slow onset (3-20 min) base ring used to maintain erection $150 - $450 bruising; numbness pain from bands blue, cool penis Avoid in sickle-cell pts ```
58
transurethral suppositories
``` Alprostadil Pellets - MUSE 125mcg, 250mcg, 500mcg, 1000mcg more acceptable to many patients than injection less effective than injection onset within 5 -10 minutes penile pain 30%; burning 10% urinate first insert suppository role penis for 10-30 sec Max of 2 doses per day Use with oral agents ??? ```
59
intracavernosal injections
``` Alprostadil Injection - Caverject ® -***DOC if pts fails PDE-5 Inhibitors -may be best for neurogenic ED -onset within 5 minutes -duration around 1 hour -injection technique must be taught [vary the site of injection] 30 - 35% discontinue use within 1 year Maximum of 1 injection/day; 3 per week Highly effective (70% to 90%) **No sexual stimulation required ```
60
alprostadil inj SE/AE
some local irritation penile pain (10-40%) - Burning; dull pain risk of priapism- Most common during dose titration cavernosal plagues or areas of fibrosis (2-12%)
61
intracavernosal injection agents
``` Alprostadil (27-30 gauge needle) -start at 2.5 mcg (many start @ 10 mcg) -usual range 10 - 20 mcg -max dose = 60 mcg -**titrate to dose that produces an erection lasting 1 hour -Efficacy better than papaverine Papaverine -7.5 - 60 mg when used alone -0.5 - 20 mg when used in combo -higher incidence of ADRs (35% incidence of priapism** and fibrosis) Phentolamine -Blocks adrenergic tone -0.5 - 1 mg doses used in combo -used in combination with papaverine ```
62
priapism treatment
``` Erection > 4 hours Pain Phenylephrine 0.1 – 1 mg Blood aspiration Saline irrigation ```
63
penile prostheses
``` Semi-rigid insert Pump irreversible only used when other treatments fail Replace every 5-10 yrs $10 - $15K ```